Capillary leak syndrome is a rare condition in which the walls of the smallest blood vessels become abnormally permeable, allowing protein-rich fluid to escape from the bloodstream into surrounding tissues. This causes a dangerous combination of plummeting blood pressure, severe swelling, and a sharp drop in blood volume that can lead to organ failure. The condition exists in two forms: idiopathic (also called Clarkson disease), which recurs without a clear external cause, and secondary, which is triggered by another illness or medication.
How the Leak Happens
Capillaries are the thin-walled blood vessels where oxygen and nutrients pass from the blood into tissues. Normally, the cells lining these vessels fit together tightly enough to keep large proteins, especially albumin, inside the bloodstream. Albumin acts like a sponge, holding water in the blood through osmotic pressure. In capillary leak syndrome, the junctions between those lining cells open up, and albumin pours into the surrounding tissue. Water follows the albumin, causing massive fluid shifts out of the bloodstream and into the spaces around muscles, organs, and skin.
The result is a paradox: the body swells with fluid while the cardiovascular system runs dangerously dry. Blood pressure drops, the remaining blood becomes abnormally concentrated, and organs that depend on steady blood flow begin to suffer. Inflammatory signaling molecules called cytokines play a role in driving this process, and they also contribute directly to kidney injury during episodes.
Idiopathic vs. Secondary Forms
The idiopathic form, Clarkson disease, typically appears in middle-aged adults and recurs in unpredictable episodes. More than 85% of people with this form have a monoclonal gammopathy, a condition in which the bone marrow produces an abnormal clone of a single antibody protein. This protein marker helps confirm the diagnosis, though researchers are still working out exactly how it contributes to the leaking.
Secondary capillary leak syndrome is a single episode triggered by something identifiable. Sepsis is the most common cause. Other triggers include autoimmune diseases, viral hemorrhagic fevers, snakebites, ricin poisoning, and complications of cancer treatment such as differentiation syndrome (seen in certain leukemias) and engraftment syndrome (a complication after bone marrow transplants). Certain chemotherapy drugs, including gemcitabine and tagraxofusp, can also set it off.
The Three Phases of an Episode
An attack of idiopathic capillary leak syndrome moves through three distinct stages, and each carries different risks.
The prodromal phase comes first. Many patients notice flu-like symptoms, fatigue, irritability, or a general sense that something is wrong. This warning window can last hours to a day or more, and recognizing it is critical because it offers the best chance to seek emergency care before the situation deteriorates.
The leak phase is when fluid actively pours out of the bloodstream. Blood pressure can drop to dangerously low levels, and blood becomes so concentrated that the proportion of red blood cells (hematocrit) rises well above normal. Albumin levels in the blood fall below 3.0 g/dL. Organs, especially the kidneys, are starved of adequate blood flow. Patients who die in this phase typically die from organ failure caused by poor perfusion.
The recovery phase begins when the capillary walls reseal. All the fluid that leaked into the tissues now gets pulled back into the bloodstream. This sounds like good news, but it creates a sudden surge of volume inside blood vessels that were running nearly empty just hours before. The heart and lungs can be overwhelmed, and flash pulmonary edema, where the lungs rapidly fill with fluid, is the leading cause of death during this phase. Managing the transition between these two stages requires careful, moment-to-moment fluid adjustments in an intensive care setting.
How It Is Diagnosed
There is no single blood test for capillary leak syndrome, so diagnosis relies on recognizing a specific pattern during or just after an episode. Clinicians look for all of the following together:
- Hypotension and shock that cannot be explained by bleeding, infection, or allergic reaction
- Hemoconcentration, meaning hematocrit rises more than 25% above a patient’s baseline or exceeds 50%, without an underlying blood disorder
- Low albumin (below 3.0 g/dL) without significant protein loss through the kidneys
- Rapid resolution of swelling once the episode passes
Because the symptoms overlap with sepsis, anaphylaxis, and other forms of shock, those conditions must be ruled out first. The combination of extreme hemoconcentration with low albumin in someone who is clearly not bleeding is the hallmark clue. In practice, many patients go through multiple episodes before the pattern is recognized and the diagnosis is made.
What Treatment Looks Like
During an acute episode, the immediate priority is maintaining blood pressure and organ perfusion. This happens in an intensive care unit with intravenous fluids and medications to support blood pressure. The challenge is striking a balance: too little fluid and the organs fail during the leak phase, too much and the excess fluid worsens tissue swelling and sets the stage for pulmonary edema during recovery. There is no standardized formula for how much fluid to give, so the medical team adjusts continuously based on blood pressure, urine output, and other real-time measurements.
Once the leak phase ends and fluid begins returning to the bloodstream, the focus shifts to preventing volume overload. Diuretics may be used carefully to help the kidneys remove the excess fluid before it floods the lungs. This transition period requires close monitoring, sometimes for days.
Preventing Future Episodes
For people with the idiopathic form, monthly infusions of intravenous immunoglobulin (IVIG) are the mainstay of long-term prevention. In a study tracking 27 patients over periods of up to 13 years, IVIG prophylaxis reduced the number of flares by 89%, from 252 episodes before treatment to just 29 after. Most patients received 2 g/kg per month, though some remained episode-free on lower doses of 1 to 1.25 g/kg per month.
IVIG infusions typically happen in an outpatient clinic or infusion center and take several hours. The treatment is not a cure; it reduces the frequency and severity of attacks but does not eliminate the underlying tendency. Patients generally continue infusions indefinitely.
Long-Term Outlook
Survival has improved significantly as awareness of the condition has grown. In a series from the Mayo Clinic, the estimated five-year overall survival rate was 76%, and the ten-year rate was 68%. The one-year survival rate was 96%, reflecting the fact that most deaths occur during acute episodes rather than from slow disease progression between attacks.
The biggest predictors of outcome are how quickly an episode is recognized and how effectively the leak-to-recovery transition is managed. Patients who learn to identify their own prodromal symptoms and get to a hospital early tend to fare better. Wearing a medical alert bracelet or carrying documentation of the diagnosis can be lifesaving, because emergency physicians may never have encountered the condition before and need to know what they are dealing with quickly.
Complications to Watch For
Beyond the immediate threats of shock and pulmonary edema, the massive fluid shifts of capillary leak syndrome can cause compartment syndrome, a condition in which swelling within a confined muscle space compresses nerves and blood vessels. This is most common in the arms and legs and can cause permanent tissue damage if pressure is not relieved in time. Kidney injury is another frequent complication, driven both by low blood flow during the leak phase and by the direct effects of inflammatory signaling on kidney tissue. Some patients require temporary dialysis during or after severe episodes, though kidney function often recovers once the attack resolves.